Restricted and repetitive behaviors (RRBs) are a core symptom of autism spectrum
disorders (ASD). There has been an increased research emphasis on repetitive behaviors; however,
this research primarily has focused on phenomenology and mechanisms. Thus, the knowledge base on
interventions is lagging behind other areas of research. The literature suggests there are
evidence-based practices to treat “lower order” RRBs in ASD (e.g., stereotypies); yet,
there is a lack of a focused program of intervention research for “higher order”
behaviors (e.g., insistence on sameness). This paper will (a) discuss barriers to intervention
development for RRBs; (b) review evidence-based interventions to treat RRBs in ASD, with a focus on
higher order behaviors; and (c) conclude with recommendations for practice and research.
The restricted and repetitive behaviors of children with autism can interfere with family functioning as well as learning and socialization opportunities for the child. To date, neither pharmacological nor comprehensive behavioral treatments have been found to be consistently effective at significantly reducing children’s engagement in repetitive behaviors. We developed Family-Implemented Treatment for Behavioral Inflexibility (FITBI) to target the full variety of repetitive behaviors found in autism. For the current study, a therapist and parents of five children with autism (mean age = 48 months) co-implemented FITBI in a clinic setting over a 12-week treatment period. Using single case design methodology, significant reductions in repetitive behaviors were found for all participants and maintenance of treatment effects for 4 of 5 participants.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.